Growing community of inventors

Basel, Switzerland

Peter Gedeck

Average Co-Inventor Count = 12.00

ph-index = 2

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 9

Peter GedeckStephen Paul Collingwood (4 patents)Peter GedeckCatherine Howsham (4 patents)Peter GedeckLee Edwards (4 patents)Peter GedeckNichola Smith (4 patents)Peter GedeckPeter Hunt (4 patents)Peter GedeckEmma Budd (4 patents)Peter GedeckGurdip Bhalay (4 patents)Peter GedeckPaul Joseph Oakley (4 patents)Peter GedeckGraham Charles Bloomfield (4 patents)Peter GedeckThomas Anthony Hunt (4 patents)Peter GedeckAndrew Dunstan (4 patents)Peter GedeckPaul Oakley (0 patent)Peter GedeckPaul Oakley (0 patent)Peter GedeckPeter Gedeck (4 patents)Stephen Paul CollingwoodStephen Paul Collingwood (28 patents)Catherine HowshamCatherine Howsham (21 patents)Lee EdwardsLee Edwards (19 patents)Nichola SmithNichola Smith (18 patents)Peter HuntPeter Hunt (16 patents)Emma BuddEmma Budd (16 patents)Gurdip BhalayGurdip Bhalay (16 patents)Paul Joseph OakleyPaul Joseph Oakley (14 patents)Graham Charles BloomfieldGraham Charles Bloomfield (12 patents)Thomas Anthony HuntThomas Anthony Hunt (8 patents)Andrew DunstanAndrew Dunstan (6 patents)Paul OakleyPaul Oakley (0 patent)Paul OakleyPaul Oakley (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Novartis Ag (4 from 3,923 patents)


4 patents:

1. 9643983 - Treating diseases mediated by blockade of the epithelial sodium channel with pyrazine-2-carboxamide derivatives

2. 9139586 - Treating diseases mediated by blockade of the epithelial sodium channel with pyrazine-2-carboxamide derivatives

3. 8697687 - Treating diseases mediated by blockade of the epithelial sodium channel with pyrazine-2-carboxamide derivatives

4. 8039472 - Pyrazine-2-carboxamide derivatives to treat diseases mediated by blockade of the epithelial sodium channel

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/4/2025
Loading…